Stifel resumed coverage of Senseonics (SENS) with a Hold rating and $9 price target The firm views its physician diligence “favorably” and ...
You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply.